Maternal depression during pregnancy and the postpartum period (lactation) is a common
debilitating condition affecting mother-fetus/-infant interactions, which can be a risk factor for …

Both untreated and SSRI antidepressant treated maternal depression during the perinatal
period can pose both short-and long-term health risks to the offspring. Therefore, it is …

Depression during pregnancy and the postpartum period is a growing health problem, which
affects up to 20% of women. Currently, selective serotonin reuptake inhibitor (SSRIs) …

A significant number of women suffer from depression during pregnancy and the postpartum
period. Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat maternal …

Depression, anxiety, and stress are common in pregnant women. One of the primary
pharmacological treatments for anxiety and depression is the antidepressant fluoxetine (Flx) …

Women of child-bearing age are the population group at highest risk for depression. In
pregnant women, fluoxetine (Flx) is the most widely prescribed selective serotonin reuptake …

Women are more likely to develop depression during childbearing years with up to 20% of
women suffering from depression during pregnancy and in the postpartum period. Increased …

There is increasing evidence that mental health concerns, stress-related mental illnesses,
and parental stress prior to conception have long-term effects on offspring outcomes …

The incidence of stress and stress-related disorders with the transition to motherhood, such
as postpartum depression, is estimated to be 20%. Selective serotonin reuptake inhibitor …

Life time prevalence of major depression disorder (MDD) is higher in women compared to
men especially during the period surrounding childbirth. Women suffering from MDD during …